B+
Bull case
30%
Probability
Target price
$48.00
Analysis reference price unavailable
Analysis 2026-04-29 · RankAlpha Sentiment Codex
AXGN
AxogenDNasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
Current thesis
The cleanest post-earnings read is that Axogen paired strong top-line growth with better gross margin and enough confidence to raise full-year revenue guidance, while payer coverage and CMS coding tailwinds give the commercial story more substance than a generic medtech growth narrative [#8-K-2026-04-28] [#10-Q-2026-04-28].
Posture
Defensive
Lead driver
Sentiment
What changed
Next scheduled catalyst: earnings 2026-10-28 · BMO.
What can break
Execution risk remains high around translating payer wins and improved CMS reimbursement into durable case-volume growth rather than a one-quarter sentiment boost.
Momentum
10
Value
42
Sentiment
54
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $42.00 · Bull $48.00 · Bear $33.00Analysis 2026-04-29; returns require an exact persisted reference.
Earnings
2026-10-28 · BMO
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-23 • Vendor: Data Vendor v1
Scores
As of 2026-10-23 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-29 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-10-23
Investment thesis
As of 2026-10-23
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-23. Definitions
Supporting evidence
What
Grade D · Defensive
Confidence Medium · Net Neutral
Target $53.55
Why
Momentum10 · Δ7d +5.1
Value42 · Δ7d +0.0
Sentiment54 · Δ7d -12.1
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Confirming evidence
- • Next scheduled catalyst: earnings 2026-10-28 · BMO.
- • Sentiment remains the lead driver in the composite, 7D delta -12.1.
Contradictions & invalidation
- • Execution risk remains high around translating payer wins and improved CMS reimbursement into durable case-volume growth rather than a one-quarter sentiment boost.
- • GAAP profitability is still weak: Q1 net loss was $19.6M, with sales and marketing, R&D, and G&A all up year over year.
- • The caution is that GAAP net loss widened to $19.6M, operating expenses remained elevated, and part of the quarter’s improvement depends on add-backs and one-time debt-extinguishment mechanics; consensus-surprise data and delayed post-print estimate revisions were not confirmed from primary sources checked, so the follow-up remains a monitoring view rather than a strong upgrade.
Catalyst clock
2026-10-28 · BMO
Q1 print plus raised 2026 outlook reset the near-term setup
Lead driver: Sentiment · See AI snapshot
Momentum
10
8% active weight
Current posture
7d trendImproving
Δ7d
+5.1
Δ21d
-15.4
Value
42
47% active weight
Current posture
7d trendFlat
Δ7d
+0.0
Δ21d
-0.2
Sentiment
54
45% active weight
Current posture
7d trendSoftening
Δ7d
-12.1
Δ21d
-10.6
Why this grade
Composite grade D. Momentum 10.4 / Value 41.6 / Sentiment 53.9
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-04-29. Scenario method
Most likely
B
Base case
45%
Probability
Target price
$42.00
Analysis reference price unavailable
Analysis 2026-04-29 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$33.00
Analysis reference price unavailable
Analysis 2026-04-29 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-10-23
Fundamentals (TTM)
As of 2026-10-23
Market Cap
$2.23B
Beta
1.00
Shares Out
58.67M
P/E (TTM) · Derived
-111.6
P/S (TTM)
6.82
P/FCF (TTM)
711.09
Rev YoY
+23.1%
EPS YoY
-334.7%
Gross Margin
+74.6%
Op Margin
-5.1%
Net Debt
$22.1M
Current Ratio
6.60
As of 2026-10-23 • Updated nightlySource: Internal modelMethods & Data